S84 Stock Overview
A biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Scope Fluidics S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł42.65 |
52 Week High | zł51.60 |
52 Week Low | zł32.85 |
Beta | -0.23 |
1 Month Change | 0% |
3 Month Change | 26.75% |
1 Year Change | 1.31% |
3 Year Change | 49.91% |
5 Year Change | n/a |
Change since IPO | 40.76% |
Recent News & Updates
Recent updates
Shareholder Returns
S84 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | -2.9% | -2.6% |
1Y | 1.3% | -8.5% | 6.9% |
Return vs Industry: S84 exceeded the German Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: S84 underperformed the German Market which returned 6.9% over the past year.
Price Volatility
S84 volatility | |
---|---|
S84 Average Weekly Movement | 10.5% |
Medical Equipment Industry Average Movement | 6.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: S84's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: S84's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 70 | Piotr Garstecki | www.scopefluidics.com |
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.
Scope Fluidics S.A. Fundamentals Summary
S84 fundamental statistics | |
---|---|
Market cap | €91.32m |
Earnings (TTM) | -€6.55m |
Revenue (TTM) | €27.92k |
3,271x
P/S Ratio-13.9x
P/E RatioIs S84 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
S84 income statement (TTM) | |
---|---|
Revenue | zł119.00k |
Cost of Revenue | zł2.78m |
Gross Profit | -zł2.66m |
Other Expenses | zł25.27m |
Earnings | -zł27.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -10.25 |
Gross Margin | -2,236.13% |
Net Profit Margin | -23,468.91% |
Debt/Equity Ratio | 0% |
How did S84 perform over the long term?
See historical performance and comparisonDividends
59.9%
Current Dividend Yield-1,646%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 22:32 |
End of Day Share Price | 2024/11/04 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Scope Fluidics S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|